Developing next generation oncology medicines through:
Novel scientific approach focused on harnessing critical cell-to-cell communications needed to revive the body’s ability to recognize, contain and eliminate abnormal cells found in cancer and precancerous conditions
Building a robust pipeline of proprietary biomarker targeted therapies to treat cancers with high unmet need
Our team brings deep oncology and organization building experience
